Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
There are several guidelines for the use of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) which are used in other countries. However, the implementation of such guidelines in each country should be modified according to the country's clinical and epidemiological situation. Therefore, The Korean Society for AIDS founded a committee in 2016 to develop guidelines for the use of PrEP for HIV that are optimal for Korea's clinical and epidemiological situation. These guidelines aim to provide comprehensive information for PrEP implementation in Korea. The recommendations contain important information for physicians working to prevent HIV infection in actual clinical fields. The committee will regularly review and revise the guidelines based on changes in PrEP administration and HIV prevention practices.
Abstract
There are several guidelines for the use of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) which are used in other countries. However, the implementation of such guidelines in each country should be modified according to the country's clinical and epidemiological situation. Therefore, The Korean Society for AIDS founded a committee in 2016 to develop guidelines for the use of PrEP for HIV that are optimal for Korea's clinical and epidemiological situation. These guidelines aim to provide comprehensive information for PrEP implementation in Korea. The recommendations contain important information for physicians working to prevent HIV infection in actual clinical fields. The committee will regularly review and revise the guidelines based on changes in PrEP administration and HIV prevention practices.
참고문헌 (4)
- 대한에이즈학회, "The 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV", AIDS in HIV-Infected Koreans, 2015, pp.47(3), 205~211[DOI]
- Grant RM, "Preexposure chemoprophylaxis for HIV prevention in men who have sex with men", N Engl J Med, 363, pp.2587~2599 (2010)
- Baeten JM, "Antiretroviral prophylaxis for HIV prevention in heterosexual men and women", N Engl J Med, 367, pp.399~410 (2012)
- Choopanya K, "Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial", Lancet, 381, pp.2083~2090 (2013)